DeoxyATP Producing hiPSC Derived Cardiomyocyte to Restore Cardiac Function in Heart Failure

0
39
Scientists engineered ribonucleotide reductase overexpressing human-induced pluripotent stem cell-derived cardiomyocytes as a novel cell therapy strategy to improve contractility and regeneration in myocardial infarction.
[Biophysical Journal]

Sorry, but the selected Zotpress account can't be found.

Abstract